Synergistic combination therapy of 5-fluorouracil, vitamin A and cobalt-60 radiation upon head and neck tumors.
We have applied a triple combination of 5-fluorouracil (5FU), vitamin A and cobalt-60 radiation (FAR therapy) to clinical treatment of head and neck tumors since 1972. The treatment of 33 patients with cancer of larynx and 15 patients with hypopharyngeal or cervical esophageal cancer with FAR therapy during three years from 1972 to 1974 resulted in highly effective synergism in vivo, and the improved points of this therapy were presented.
D003037:Cobalt Radioisotopes; D004359:Drug Therapy, Combination; D004938:Esophageal Neoplasms / Q000628:therapy; D005472:Fluorouracil / Q000008:administration & dosage*; D006258:Head and Neck Neoplasms / Q000628:therapy*; D006801:Humans; D007013:Hypopharynx; D007822:Laryngeal Neoplasms / Q000628:therapy; D010610:Pharyngeal Neoplasms / Q000628:therapy; D011867:Radioisotope Teletherapy; D014801:Vitamin A / Q000008:administration & dosage*
D003037:Cobalt Radioisotopes; D014801:Vitamin A; D005472:Fluorouracil